Sanofi (SNY), Regeneron (REGN) Update on Two Phase 1b Dupilumab Trials
Go back to Sanofi (SNY), Regeneron (REGN) Update on Two Phase 1b Dupilumab Trials| Regeneron (NASDAQ: REGN) | Delayed: 831.17 -9.67 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $840.84 | 52 Week High | $592.36 | |||
| Open | $831.70 | 52 Week Low | $325.35 | |||
| Day High | $840.82 | P/E | 218.15 | |||
| Day Low | $830.17 | EPS | $3.81 | |||
| Volume | 272,778 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.25 -0.58 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.83 | 52 Week High | $44.76 | |||
| Open | $45.65 | 52 Week Low | $36.81 | |||
| Day High | $45.74 | P/E | N/A | |||
| Day Low | $45.06 | EPS | $0.00 | |||
| Volume | 1,913,225 | |||||

